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Abstract: 
 
The original aims of our study have been to investigate in sleep-deprived mice, the effects of 
modafinil administration on spatial working memory, in parallel with the evaluation of neural 
activity level, as compared to non sleep-deprived animals. For this purpose, an original sleep-
deprivation apparatus was developed and validated with continuous electroencephalography 
recording. Memory performance was evaluated using spontaneous alternation in a T-maze, whereas 
the neural activity level was estimated by the quantification of the c-Fos protein in various cerebral 
zones. This study allowed altogether:  
First, to evidence that a diurnal 10-hr sleep deprivation period induced an impairment of 
spatial working memory.  
Second, to observe a decrease in c-Fos expression after sleep deprivation followed by a 
behavioural test, as compared to non sleep-deprived mice. This impairment in neural activity was 
evidenced in areas involved in wake-sleep cycle regulation (anterior hypothalamus and supraoptic 
nucleus), but also in memory (frontal cortex and hippocampus) and emotions (amygdala). 
Finally, to demonstrate that modafinil 64 mg/kg is able to restore on the one hand memory 
performance after a 10-hr sleep deprivation period, and on the other hand, the neural activity level 
in the very same brain areas where it was previously impaired by sleep deprivation and cognitive 
task. 
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1. Introduction: 
 
Modafinil (chemical name: [(diphenylmethyl) sulfinyl]-2 acetamide) has been reported as 
having stimulant and awakening properties without amphetamine-like side effects (Bastuji and 
Jouvet, 1988 ; Hermant et al., 1991 ; Lyons and French, 1991). Modafinil (Modiodal®) is 
successfully used in the treatment of narcolepsy and idiopathic hypersomnia without interfering, 
however, with nocturnal sleep (Bastuji and Jouvet, 1988). When administered to healthy subjects, 
modafinil provides a military interest in cases of total or partial sleep deprivation resulting from 
either continuous or sustained operation (Lagarde et al, 1995 ; Lagarde and Batejat, 1995 ; 
Caldwell et al., 2004).  
Its mechanism of action could involve both norepinephrine and dopaminergic systems, 
through ascending pathways that are likely to promote wakefulness by activating the cortex and 
other forebrain targets, possibly through interaction with the hypocretin/orexin system (Boutrel and 
Koob, 2004 ; Willie et al., 2005).  Moreover, modafinil is able to interact with norepinephrine and 
dopamine transporters in the brain (Madras et al., 2006), and to enhance the extracellular level of 
dopamine in the nucleus accumbens in rats (Murillo-Rodriguez et al., 2006), probably via the 
involvement of a GABAergic mechanism (Ferraro et al., 1996). Moreover, behavioural activity 
induced by modafinil administration could be mediated by brain alpha 1B-adrenoceptors (Stone et 
al., 2002). The mechanism of action of modafinil could also involve a reduction of GABA release 
in the cerebral cortex (Tanganelli et al., 1992 ; Piérard et al., 1997) as well as an involvement of 
excitatory amino acids system (Piérard et al., 1995 ; 1997) and its receptors (Lagarde et al., 1996). 
Modafinil could also enhance brain energy metabolism, by increasing the energetic pool of 
phosphocreatine in cortex, thus contributing vigilance-enhancing properties of this drug (Piérard et 
al., 1995). Moreover, we recently demonstrated that modafinil administered in chronically-stressed 
mice could interfere with glucocorticoids (Piérard et al., 2006), that are involved in the regulation 
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of dopaminergic neurotransmission (Czyrak et al., 2003). However, the mechanism of action of 
modafinil,--as yet not fully understood--,  remains largely surrounded by controversy (Saper and 
Scammel, 2004).  
Concerning the neuroanatomical brain targets of modafinil, some authors observed that c-Fos 
protein expression increased in the anterior hypothalamus following modafinil administration (Lin 
et al., 1996 ; Engber et al., 1998) and orexin-containing neurons (Scammel et al., 2000). Neither 
one of these studies, however, was performed after a sleep deprivation period followed by cognitive 
tasks; hence the brain targets of modafinil remain a matter for debate (Gallopin et al., 2004).  
From a functional viewpoint, specific neurocognitive domains including executive attention, 
working memory and higher cognitive functions are particularly vulnerable to sleep loss (Durmer 
and Dinges, 2005 ; Mu et al., 2005). More specifically, sleep loss, even moderate, compromises the 
function of neuronal circuits critical to subsecond attention allocation during working-memory 
tasks (Smith et al., 2002). The associated decrease in brain activity during working-memory tasks 
appears to be a function of the individual sleep-deprivation vulnerability (Mu et al., 2005). 
Moreover, executive functioning is largely dependent on activity in the prefrontal cortex and 
affected negatively by one night sleep deprivation (Nilsson et al., 2005).  
In addition, several studies without sleep deprivation have demonstrated that modafinil is able 
to improve working memory both in animals (Béracochéa et al., 2001) as well as in humans 
(Müller et al., 2004). There is further evidence that modafinil enhances learning processes after 
chronic (Béracochéa et al., 2002) or acute (Béracochéa et al., 2003) systemic administration in 
mice. To the best of our knowledge, very few studies investigated the effect of modafinil 
administration on memory and/or neural activity after sleep deprivation. In one of these studies 
(Pigeau et al., 1995), however, modafinil seems to restore short-term memory after prolonged sleep 
deprivation in humans. 
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Hence, the original aims of our study have been to investigate in sleep-deprived mice, the 
effects of modafinil on spatial working memory with subsequent evaluation of the neural activity 
level in various cerebral zones, as compared to non sleep-deprived animals. 
 
2. Materials and Methods: 
 
2.1. Animals: 
The study was conducted using male mice of the C57BL/6J strain (Iffa-Credo, Lyon, France). 
Upon arrival, mice were housed collectively in colony cages (40 cm long x 25 cm high x 20 cm 
wide) matched for weight and placed in an animal room (22°C ambient temperature ; automatic 
light cycle 07:00 a.m. and 07:00 p.m.) with free access to food and water. Fifteen days before 
testing, mice were placed in individual cages and manipulated 10 minutes each day, in order to 
reduce interference with the experimenter. They were 5 months old on the day of the experiment. 
The present study was carried out in compliance with the European Convention for the 
protection of Vertebrate Animals used for Experimental and other Scientific Purposes, and under 
the agreement # 94001 delivered by the French Ministry of Defense, after the protocol was 
examined by the local ethical committee. 
 
2.2. Sleep deprivation model: 
2.2.1. Apparatus: 
   An original automatic total sleep-deprivation apparatus ("water box") was developed jointly 
by LNC and IMASSA in order to reduce stress and physical fatigue [Fig. 1]. It is constituted by a 
water tank of grey PVC (10 mm thickness) with rectangular section (42 x 32 cm) and 22 cm high, 
containing temperature-regulated water at 31° C. In the middle of the tank two small square 
platforms (10 x 10 cm), without edge, are closely adjusted side by side. The surface of each 
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platform is squared with deep (3 mm) orthogonal grooves in order to facilitate water 
evacuation during upward movements, and consequently to avoid that animals slip or get 
their feet wet. The platforms move independently with compressed-air jack. In the start position, 
both platforms slightly emerge from water level. Then, each platform alternatively moves below 
and above the surface of the water, thus forcing the mouse to a permanent motion in order to avoid 
water contact. The completion of one platform revolution needs 10 sec. During this period, 
each platform remains stable over the surface of the water for 5 sec, then goes 60 mm down 
for 2.5 sec and immediately goes up for 2.5 sec until the initial position. Throughout the days 
prior to the behavioural task, the mice were allowed to become familiar with the water box to 
reduce their stress level. Thus, they learn to stay at the junction of both platforms, allowing 
them to move from the sinking platform with a very short motion (i.e. 1 step forward then 
backward every 10-sec period). 
 
2.2.2. Validation of sleep deprivation model by EEG recording:  
The determination of the efficacy of our original sleep deprivation apparatus was performed 
on 14 independent mice, divided into a 10-hr diurnal sleep-deprived group (n = 7) and a control 
(non sleep-deprived) group (n = 7). All the mice were monitored by means of continuous video and 
EEG recording for 10 hours, between 08:00 a.m. and 08:00 p.m. Control mice were also placed in 
the sleep deprivation apparatus during the same period, with both platforms unmoved, thus 
allowing them to sleep ad libitum. Eight days before the validation experiment, animals were 
anaesthetized in order to place in parietal position 2 silver wire electrodes close to the dura-matter. 
Moreover, one reference electrode was inserted in the frontal bone. All the electrodes were fixed 
using acrylic dental cement (Palavit®). The animals were then allowed to recover for 8 days. On 
the day of the experiment, the animals were placed in the sleep deprivation apparatus. Cortical 
electric activity was recorded on a Medelec® 1121 EEG table. Further, spectral analysis was 
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performed with the Somnologica® v.3.1.3 software. In addition to the observation of animals, the 
wakening status was characterized on recordings by low amplitude (< 200 µV) and high frequency 
(> 40 Hz) waves, and the sleep status by the occurrence of waves with an amplitude higher than 
200 µV, and of δ (0.5 - 4.5 Hz) or θ (4.5 - 9.5 Hz) frequencies. Signal analysis was performed 
continuously throughout the 10 hrs of sleep deprivation, for 5 s periods. Moreover, selective 
spectral analysis was performed for power in the (8-9 Hz) θ band frequencies, considered as an 
index of alertness or attention during wakefulness in the rodents (Willie et al., 2005). 
 
2.3. Memory testing: 
The behavioural task used to test working memory [Fig. 2] is based on spontaneous 
alternation behavior (SA), which does not require the use of food reinforcement to emerge. SA is 
the innate tendency of rodents whereby over a series of trials run in a T-maze, they alternate at each 
successive trial the choice of the goal arm ((except for the first trial). Repetitive testing constitutes a 
potent source of proactive interference. From trial to trial, accurate performance at a given trial (N) 
requires for subjects to be able to discriminate the specific target trial N-1 from the interfering trial 
N-2. The target information required for successful performance varies from trial to trial, so that the 
subject is not only required to keep temporarily in short-term memory specific information, but also 
to reset it over successive runs. The resetting mechanisms and cognitive flexibility required to 
alternate over successive runs are major components of working memory processes. Working 
memory is a component of the sequential alternation task, since SA rates are dependent on the 
length of the intertrial delay interval, and/or  the place of the trial in the series. Indeed, repetitive 
testing constitutes a potent source of proactive interference. Thus, the sequential alternation 
procedure is relevant to assess delay-dependent working memory in mice (Béracochéa and Jaffard, 
1990 ; Béracochéa et al., 1995).  
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The tests were carried out in a T-maze constructed of opaque grey PVC. Stem and arms were 
35 cm long, 10 cm wide, and 25 cm high. The start box (10 x 12 cm) was separated from the stem 
by a vertical sliding door. Vertical sliding doors were also placed at the entrance of each arm. A 
low-intensity diffuse illumination (10 lux) was provided above the apparatus. Between two trials, 
the apparatus was cleaned using 70 % alcohol and water, in order to remove any olfactive cue. An 
alternation response was considered each time the subject entered the arm opposite to the one 
visited on the immediately previous trial. Alternation rate was expressed in percentage relative to 
the maximal alternation rate of 100 % (obtained when the subject never returned into the same arm 
over two consecutive trials). 
For all the animals, the following procedure was used: 
On D-4 (four days before the day of the test), all the animals were allowed to freely explore 
the apparatus 10 min in the morning and 10 min in the afternoon, in order for them to become 
familiar with the experimental conditions. Between both sessions, animals were replaced in their 
individual cage in the animal room. 
From D-3 to D-1, the animals had to complete two daily training sessions of SA (6 sessions in 
total), in order to foster the development of the alternation behavioural pattern and to familiarize 
them with the opening and/or closing of the doors over successive runs. Each session included 6 
trials, separated by a 30-s intertrial delay. 
On D0 (the day of the experiment), behavioural testing was performed 30 min after the end of 
the sleep deprivation period and modafinil (or vehicle) injection. This delay is required for the 
development of the pharmacological action of modafinil. The animals were not allowed to 
sleep during this 30-min delay, because recovery sleep might interfere with Fos staining 
(Cirelli, 2002). As stated here above, all the subjects were exposed to 6 successive trials (intertrial 
delay: 30 s). 
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2.4. Behavioural study:  
Previous experiments have shown that a sleep deprivation period of 24 hrs totally disrupted 
the ability of mice to run the alternation task, the mice choosing to sleep rather than to explore the 
maze. In contrast, a 3-hr sleep deprivation period had no effect on memory performance as regards 
non sleep-deprived animals (unpublished data). According to these previous experiments, we 
decided to study the effects on memory of an intermediate 10-hr sleep deprivation period and 
modafinil. Thirty-eight mice randomized between the 5 following groups were used: i) NSD (non 
sleep-deprived ; n = 8)  ; ii) SD (10-hr sleep-deprived ; n = 8)  ; iii) SD + vehicle (10-hr sleep-
deprived + vehicle ; n = 6) ; iv) SD + M32 (10-hr sleep-deprived + modafinil 32 mg/kg ; n = 8) ; v) 
SD + M64  (10-hr sleep-deprived + modafinil 64 mg/kg ; n = 8). The sleep deprivation period took 
place from 08:00 a.m until 08:00 p.m. 
Modafinil administration: modafinil, insoluble in water, was suspended in an 0.5 % solution 
of gum tragacanth (vehicle). Modafinil suspension or vehicle alone were injected i.p. after the sleep 
deprivation period, 30 minutes before the behavioural test session began. According to our previous 
study (Béracochéa 2001 ; Piérard 2006), the administered doses of modafinil were of 32 and 64 
mg/kg for the M32 and M64 groups respectively (injected volume: 0.1 ml/10 g mouse).  
Statistical analysis: in our behavioural procedure, only mice having alternated at the second 
trial were selected for further statistical analysis of behavioural data (Piérard et al., 2006). This 
behavioural criterion ensured that motor abilities and motivation to alternate are equivalent between 
subjects and not impaired by sleep deprivation and/or modafinil. Thus, all the groups exhibit 
alternation rates of 100 % at the second trial [Fig. 5]. Using this procedure, only one mouse of the 
[SD] group and one mouse of the [SD + M32] group were not taken into account for analysis. 
Moreover, mice of the [SD] and [SD + vehicle] groups were gathered together for statistical 
analysis. Statistical analysis was performed using Statview® v.5.0 software. ANOVA was 
performed to evidence the effects of a 10-hr sleep deprivation period (followed or not by modafinil 
 9
administration) on alternation rates. Further comparisons between individual groups were 
performed with the Scheffe post-hoc test. Significance was accepted at p values below 0.05. 
 
2.5. Immunohistochemical study (c-Fos analysis): 
The quantification of c-Fos protein expression in the brain is currently used as a marker of 
functional activity (see Krukoff 1999 for review). C-Fos analysis was performed on the 10-hr 
sleep-deprived groups, as compared to the control non sleep-deprived group [NSD]. Immediately 
after the alternation task, 12 mice of [NSD], [SD], and [SD + M64] groups (4 randomized mice for 
each group) were anaesthetized (ketamine 100 mg/kg + xylazine 10 mg/kg ; injected volume: 0.1 
ml/10 g mouse). They were then perfused in the left ventricule with 100 ml NaCl 0.9 % followed 
by 100 ml paraformaldehyde 4 % to fix tissue before the brain was removed. Fixed brains were cut 
in frontal sections of 50 µm each, using a freezing microtome. Sections were incubated with a 
primary antibody specific of Fos protein (Calbiochem®), then with a biotinyled secondary antibody 
(specific of the primary antibody), and finally with the avidine-biotine-peroxydase complex 
Vectastain®). C-Fos immunoreactivity was revealed using diaminobenzidine. Different brain 
structures were analysed with the image analysis system Biocom 2000 (visiol@b 2000 software) 
coupled with a microscope. The analysis concerned the brain structures involved i) in the regulation 
of the wake-sleep cycle : anterior hypothalamus and supraoptic nucleus, ii) in memory : frontal 
cortex and hippocampus areas (CA1 and dentate gyrus) and iii) in emotions : amygdala.  
The quantification of Fos-positive nuclei in the studied brain regions following the alternation 
task was expressed in mean counts/mm2. Moreover, for a given area, the results were expressed in 
relative variations as compared to [NSD] mice. Intra-zone comparisons to [NSD] mice were 
performed by the Student t test. Significance was accepted at p values below 0.05.  
 
 
 10
 3. Results: 
 
3.1. EEG validation of the sleep deprivation model: 
The behavioural observation of video recordings obtained during the 10-hr sleep deprivation 
period shows that mice remained awake 100 % of the time in the water-box. The [Fig. 3] represents 
an EEG sample obtained during the occurrence of a short sleep event. The [Fig. 4], obtained from 
EEG data, gives the repartition (in terms of numbers and mean durations of sleep events) during the 
10-hr diurnal sleep deprivation period. The mean cumulated duration of sleep episodes during the 
10-hr sleep deprivation period was of about 0.66  ± 0.23 min (m ± SEM ; n = 7), i.e. 0.11 ± 0.04 %, 
whereas it was of 314.13 ± 27.56 min (m ± SEM ; n = 7), i.e. 52.36 ± 4.59 % in control animals. 
Thus, the efficacy of our sleep-deprivation apparatus is of  99.79 %. The greatest number and 
duration of sleep episodes occurred during the first hour spent on the apparatus (between 08:00 and 
09:00 a.m.), i.e. at the beginning of the diurnal rest phase for rodents. On the other hand, spectral 
analysis of the θ band frequencies (8-9 Hz) during wakefulness shows that attention is continuously 
impaired from the first hour of the sleep deprivation (08:00-09:00 a.m.) until the fourth hour 
(11:00-12:00 a.m.). Minimal attention also occurred for the seventh hour (02:00-03:00 p.m.). Then 
attention increased until the end of the sleep deprivation period (i.e. 05:00-06:00 p.m.). 
 
3.2. Effects of sleep deprivation: 
3.2.1. On spatial working memory:  [Fig. 5] 
A two-way ANOVA on the overall  4 groups [NSD] (n = 8) ; [SD] (n = 13) ; [SD + M32] (n = 
7) and [SD + M64] (n = 8) evidences a significant interaction between groups and interfering trials 
(trials # 3-6) [F(3,32) = 4.47 ; p < 0.009].  
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Furthermore, individual comparisons show that the alternation rate of the [SD] group is 
significantly decreased (p < 0.001) as compared to the [NSD] group, thus evidencing the 
impairment  spatial working memory induced by a 10-hr total sleep deprivation period.  
 
3.2.2. On neural activity:  [Table I] 
For a given area, ANOVA performed on groups (SD, NSD, SD+M64) showed a global 
significant inter-groups difference as mentioned in Table 1 (p<0.05 in all comparisons). The mice 
of the [SD] group show a significantly decreased c-Fos staining in the anterior hypothalamus and 
supraoptic nucleus (- 23 and - 18 % respectively ; p < 0.05), as compared to [NSD] mice. 
Moreover, the decrease in c-Fos staining is also evidenced in CA1 and dentate gyrus of 
hippocampus (- 18 % ; p < 0.05), frontal cortex (- 15 % ; p < 0.03) and amygdala (- 13 % ; p < 
0.05), as compared to [NSD] mice. 
 
3.3. Effects of modafinil after a 10-hr sleep deprivation period: 
3.3.1. On spatial working memory:  [Fig. 5]  
Individual comparisons show that the alternation rate of the [SD + M32] group is not 
significantly different from [SD] group. On the contrary, the alternation rate of the [SD + M64] 
group is significantly increased as compared to the [SD] group (p < 0.001), but not significantly 
different from the [NSD] group. Thus, modafinil (64 mg/kg, but not 32 mg/kg) is able to restore the 
spatial working memory performance that was previously impaired by a 10-hr sleep-deprivation 
period. 
 
3.3.2. On neural activity:  [Table I] 
For all the studied brain regions, statistical analysis shows that c-Fos staining for the [SD + 
M64] group is not different as compared to [NSD] group. Thus, modafinil (64 mg/kg) is able to 
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restore neural activity in the very same cerebral structures where it was previously decreased by a 
10-hr sleep deprivation period. 
  
4. Discussion: 
 
The current study evidenced that a total 10-hr diurnal sleep deprivation is able to impair 
working memory performance in mice. Moreover, the 10-hr sleep deprivation period is able to 
impair neural activity in the cerebral areas involved in sleep/wake cycle regulation, memory and 
emotions. Both these impairments could be completely reversed by modafinil administration at the 
dose of 64 mg/kg i.p. (but not of 32 mg/kg).  
Thus, the present study shows for the first time that modafinil is able to restore both memory 
performance and neural activity previously impaired by a prolonged sleep deprivation. Besides 
pharmacological means (for example IMAO that completely suppresses paradoxical sleep), or 
gentle handling (Palchykova et al., 2006), several sleep deprivation apparatuses (mainly for rats or 
bigger animals) are described in the literature (Vogel et al., 1975 ; Rechtschaffen et al., 1989). 
Furthermore, some of them allow selective REM or non REM sleep deprivation, with the help of 
polygraphic recordings. In the present study, we used an original total sleep deprivation model. We 
can assume that stress in our sleep deprivation model is not a cause for the memory impairments 
observed in SD subjects. Indeed, the advantage of our alternative platforms apparatus (water box) is 
to induce very low stress level. Thus, at any moment the animal has an emerging security  platform 
readily available, allowing it to stay out of water. Furthermore, physical fatigue is minimal because 
the animal learns to stay at the junction of both platforms, thus allowing it to leave the downward 
platform very quickly, with a very short motion. In addition, the stress effect is observable only 
during the first hour of the SD period, and we found that mice submitted to a 3 hours SD period did 
not evidenced memory impairments (unpublished data). This means that the stress component 
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involved in the first hour is not important enough to induce a memory deficit. Continuous EEG 
analysis (performed on independent mice during the validation phase) allowed to determine the 
efficacy  score (99.79 %) of our sleep deprivation apparatus. On the other hand, EEG recording 
allowed to evidence variations of attention by the means of the spectral analysis of the θ band 
frequencies (8-9 Hz) during wakefulness. 
In humans, modafinil administered in non sleep-deprived subjects at a therapeutic dose (100 or 
200 mg) has no effect on spatial working memory, nor on long-term memory. Thus, modafinil 
could not be considered as a cognitive enhancer in non sleep-deprived healthy subjects (Randall et 
al., 2005). On the opposite, previous results of our laboratory obtained on healthy sleep-
deprived adults (after a 60-hr sleep deprivation period) showed that modafinil is able to 
restore the overall psychomotor performance to the non sleep-deprived levels (Lagarde and 
Batejat, 1995). This result was confirmed by a recent work (Wesensten, 2006). Thus, we 
logically decided in the present study to use the non sleep-deprived animals as controls for 
post-hoc statistical analysis. The latter result is consistent with the present study, in which the 
powerful wakening effect of modafinil is clearly evidenced on working memory performance after 
10 hrs sleep deprivation. Indeed, after modafinil administration, these animals retrieved their 
exploratory behavior and a normal working memory performance. 
Fos is the protein product of the immediate early gene c-fos. In response to a stimulus, one 
observes first an increase in c-fos mRNA levels, which is soon followed by the synthesis of Fos 
protein. Fos protein is a transcription factor that, by binding to DNA regulatory regions, can control 
the expression of many "target" genes. In the CNS, c-fos can be induced by many different stimuli, 
and it is probably a simpler task to list those stimuli that do not induce c-fos. However, the 
expression of Fos protein is classically considered as a relevant indicator of neural activity. In 
sleep-deprived rats, c-fos expression in several brain areas is higher with respect to control animals 
(Cirelli et al., 1995). Indeed, after a few hours of spontaneous waking or sleep deprivation, c-fos 
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and other IEGs is high in cerebral cortex, hypothalamus, septum, and several thalamic and 
brainstem nuclei (Cirelli and Tononi, 2000). In addition, Terao et al. (2003) evidenced a 
statistically significant increase in c-fos mRNA in mouse cerebral cortex, basal forebrain, thalamus 
and cerebellum following a 6-hr sleep deprivation. Contrariwise the expression of c-fos in mouse 
brain is very low after a few hours of sleep/inactivity (Basheer et al., 1997). Considered together, 
these results indicate that c-fos expression is associated with waking, but is not proportional to the 
amount of previous waking (Cirelli and Tononi, 2000). Interestingly, however, it is noteworthy  
that none of the above studies submitted animals to a behavioural task before Fos analysis. 
However, Stone et al (2006) reported that brain areas involved in positively motivated behavior 
exhibited a decrease in Fos activity, in contrast to brain areas mediating stress effects (e.g. 
Paraventricular nucleus) which exhibited an increase in Fos activity. In the present study, we 
evidenced significant decreases in c-fos staining after a 10-hr sleep deprivation in all the studied 
brain areas, as compared to non SD mice. Thus, since our SD model did not induced stress, our 
results corroborate the general conclusions drawn by Stone et al (2006) concerning the areas which 
are not involved in stress effects, thus strengthening our hypothesis that stress is not involved in the 
SD-induced memory impairments. Thus, we can hypothesise that the combination between sleep 
deprivation on the one hand with the behavioural  task (spontaneous alternation) on the other hand 
might be responsible for these observed decreases in Fos staining.  Indeed, this hypothesis is 
sustained by the work of Célérier (2004), who already found that the combination of a moderate 
stress with a cognitive task reduced c-fos expression in the hypothalamus, whereas stress only 
increased Fos staining in this area, as compared with non-stressed animals. Concerning the effects 
of modafinil on Fos labelling in brain, modafinil induced marked Fos staining in anterior 
hypothalamus on cat (Lin et al. ; 1996). Moreover, Engber et al. (1998) found by c-Fos 
immunohistochemistry that the neural targets for modafinil not only include anterior hypothalamus, 
but also amygdala. These results are consistent with our present work, where Fos staining was 
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previously decreased in anterior hypothalamus and amygdala after sleep deprivation and cognitive 
task, and then restored by modafinil. However, Scammel et al. (2000) did not evidence a significant 
increase in Fos expression in the anterior hypothalamic area after modafinil administration in rat. 
Moreover,  the debate remains open about a possible relationship between neural activity on 
the one hand, and memory performance on the other hand. A spatial relationship seems at least to 
exist, because neural activity variations (evidenced by Fos staining after sleep deprivation followed 
or not by modafinil administration), partly occurred in the two main brain areas that are involved in 
memory (i.e. frontal cortex and hippocampus). However, the temporal relationship between 
memory performance and neural activity changes is not clearly established. In addition, further 
studies are also needed in order to determine the mechanism of action of modafinil on the recovery 
of both memory performance and neural activity after sleep deprivation. One could also wonder if a 
single mechanism of action could explain both the wakening and memory-enhancing effects of 
modafinil.  
A specific contribution of the present study is the evidence, in sleep-deprived mice, of a 
modafinil-induced enhancement of Fos labelling in amygdala, the main brain area involved in 
emotions. Indeed, such a finding corroborates our previous study (Piérard et al., 2006) in which we 
observed an interaction between modafinil, stress and memory. Moreover, as for many memory 
enhancing drugs, such as beta-CCM (Célérier et al., 2004), an anxiety-like action of modafinil was 
previously found (unpublished data). In addition, anxiogenic treatments such as cholecystokinin 
(CCK) fragments increase Fos labelling in several brain regions including amygdala and 
hypothalamus (Netto and Guimarães, 2004). Thus, the anxiety-like action of modafinil might 
contribute to its neural activity-recovering effect. 
Finally, it will be relevant to extend the present immunohistochemical experiment by the 
dynamic study, not only of neural activation (using Fos staining), but also as regards neuronal 
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plasticity (by the means of the quantification of MAP2 and synaptophysin protein expression) after 
sleep deprivation and/or modafinil administration, in the same brain areas as above. 
 
5. Conclusion: 
 
 The current study used a new and original low-stress total sleep deprivation device, that 
allowed to evidence that a diurnal 10-hr sleep deprivation period induced an impairment of spatial 
working memory. We observed in the same animals a decrease in Fos protein expression (maybe 
due to the combination between sleep deprivation and behavioural test), in areas involved in wake-
sleep cycle regulation (anterior hypothalamus and supraoptic nucleus), but also in memory (frontal 
cortex and hippocampus) and emotions (amygdala). In a second step, we observed the ability of 
modafinil (64 but not 32 mg/kg) to restore, after 10 hrs sleep deprivation, both the previously 
impaired working-memory performance and neural activity. 
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Figure captions: 
 
 
Figure 1:  
Total sleep deprivation apparatus "water box". 
 
Figure 2: 
Behavioural task (spontaneous alternation in a T-maze) used to assess delay-dependent working 
memory in mice. 
 
Figure 3: 
EEG sample obtained during the occurrence of a short sleep event (14 sec). 
 
Figure 4: 
Mean repartition of sleep events during a diurnal 10-hr sleep deprivation period (n = 7 mice). 
Left scale: mean number (bars)  -  Right scale: mean duration  (lines) in min. 
 
Figure 5: 
Effects of a 10-hr sleep deprivation period and modafinil on spatial working memory performance. 
Results are expressed as means ± SEM. NSD: non sleep-deprived ; SD: 10-hr sleep-deprived ; SD 
+ M32: 10-hr sleep-deprived + modafinil 32 mg/kg ; SD + M64: 10-hr sleep-deprived + modafinil 
64 mg/kg.  ; ***: p < 0.001.  
  
Table I: 
Quantification of Fos-positive nuclei immediately after the alternation task. Results are expressed 
as mean counts/mm2  ±  SEM. NSD: non sleep-deprived ; SD: 10-hr sleep-deprived ; SD + M64: 
10-hr sleep-deprived + modafinil 64 mg/kg. For each brain structure, F value and significance of 
ANOVA is given (italic characters).  Intra-zone comparisons to NSD animals : *: p < 0.05 ; n.s. : 
non significant. 
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CA1  
(F(2,9)=4.5; p<0.04) 
 
125 ± 12 
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115 ± 9  n.s. 
 
Dentate gyrus 
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